Arkolith/Insider Trading/CRBP/Form 4

Cohen Yuval

Chief Executive Officer, DirectorCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Feb 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$62K
Net Open-Market Flow
-$62K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2025Sell(S)7K$8.76$62K138K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-022512) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML